Episode 3. Vonoprazan is already gaining ground with doctors — but the real opportunity is on the distribution side. This episode breaks down why a Vonoprazan PCD pharma franchise makes business sense right now, from repeat demand driven by chronic GERD patients to monopoly rights and strong profit margins. We also cover the HP kit for H. pylori therapy and the Vonoprazan Domperidone combination — two products that round out a solid gastro portfolio. You can explore Vonoprazan 10mg and 20mg tablets directly on the Janus Biotech product page. If you missed the earlier episodes, Episode 2 covered Vonoprazan as a next-gen acid reflux treatment and Episode 1 explored the rise of niacinamide serum manufacturing in India.

In Episode 2 of The Janus Pharma Insights, we explore Vonoprazan — a potassium-competitive acid blocker (P-CAB) offering fast, lasting relief for GERD, reflux esophagitis, and peptic ulcers. We look at why it's gaining traction with healthcare providers and how Janus Biotech supplies high-grade Vonoprazan 10 mg and 20 mg tablets to distributors and pharmacies across India. Looking for a reliable supply partner? Visit janus.co.in to learn more.
🔗 Read more: https://janus.co.in/product/vonoprazan-20-mg-10mg/

In this episode of The Janus Pharma Insights, we explore the rise of niacinamide serum manufacturing in India and why skincare brands are rapidly investing in niacinamide-based products. From growing consumer awareness and dermatologist-backed skincare trends to private label cosmetic manufacturing and third-party serum production, this podcast discusses the factors driving demand in the Indian skincare industry.

Listen to insights on niacinamide serum manufacturing, cosmetic manufacturing in India, private label skincare products, serum formulation trends, and the growing business opportunities in the skincare market. This episode also highlights how skincare brands are partnering with experienced cosmetic manufacturers for scalable and quality-focused serum production.